Valuation
- Market cap
- 0
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 71,700
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- 1.14
- Analysts
- Strong Buy
- Price target
- —
Company profile
Imagenetix, Inc. engages in the research, development, and commercialization of compositions to reduce body fat and enhance overall body composition. It offers an inference engine for CT, MRI, and X ray studies, a clinician review workstation that surfaces model outputs within the diagnostic viewer, and an enterprise analytics hub for quality and utilization reporting. The company was founded in 1996 and is based in...
Show more
Imagenetix, Inc. engages in the research, development, and commercialization of compositions to reduce body fat and enhance overall body composition. It offers an inference engine for CT, MRI, and X ray studies, a clinician review workstation that surfaces model outputs within the diagnostic viewer, and an enterprise analytics hub for quality and utilization reporting. The company was founded in 1996 and is based in San Diego, California.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 858-674-8455
- Website
- https://www.imagenetix.net
- Address
- 10845 Rancho Bernardo Road, Suite 105, San Diego, United States
Latest news
No headlines yet.
